Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VF Corp (VFC) vs GeneDx Holdings Corp (WGS) Price & Performance

VF CorpTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

VF Corp vs GeneDx Holdings Corp — how do they compare? VF Corp trades at $16.88 (market cap $6.62B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: VF Corp is far larger — about 3.7× GeneDx Holdings Corp's market cap, and VF Corp pays a 2.13% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

VFCWGS
Market Cap
$6.62B$1.80B
Sector
Consumer CyclicalTechnology
52-Week High
$21.55$167.51
52-Week Low
$11.66$34.51
Enterprise Value
$10.77B$1.80B
Dividend Yield
2.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VF Corp

VFC trades at $16.91, down 0.41% with a bearish technical signal. The company shows mixed fundamentals with declining revenue from $11.8B in 2022 to $9.5B in 2025, though recent quarters beat EPS estimates. Net income turned negative in 2025 at -$190M, but 2026 projections show recovery to $255M profit. Valuation metrics appear reasonable with P/E of 26.38 and P/S of 0.7, while analyst consensus targets $19.33 with 43% buy ratings.

VFC faces turnaround challenges with weak Vans performance and consumer headwinds, but improving margins and debt reduction provide catalysts. The stock offers potential upside to analyst targets if brand recovery continues, though execution risks remain elevated given recent volatility and competitive pressures in apparel retail.

GeneDx Holdings Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About VF Corp

VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.

Read more on VFC

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS